Thursday, 4 May 2023

Week 403 Review - Numis Corp buy-out announcement reduces losses but Optibiotix at an all time low

Generally a flat week with most shares edging downwards. NUM:Numis Corp nearly rescued things, but a 0.5p drop in OPTI:Optibiotix wiped out most of last week's gains, with a worsening of the deficit between cost and value of £747 to £124,689 and reduction in total value to £55,786.

The only big faller was CAML:Central Asia Metals which dropped 7% to go 26% down. I really don't understand what's going on here. The company is amazing, but there's no interest in the shares, despite a massive dividend and track record of stable profits. I desperately want to increase my holding at these prices, but have no ammo.

Share of the Week by a mile is NUM:Numis Corp which announced it was being bought out at a 67% premium to the current share price. Unfortunately that share price was already 23% down on when I bought it, so the price zoomed up by 48% of the price I paid to go 25% up. I'm holding them until the takeover because although the price won't go up again, there are 2 dividends planned so I may as well get those and register some potential profits for a while.

Here's the ISA and shares portfolio after week 39 of year 8.

Weekly Change
Cash£169.75+£0
Portfolio cost£86,344.72+£0
Portfolio sell value
(bid price-commission)
£25,204.74(-70.8%)-£604.89
Potential profits£22.87+£22.87
Yr 8 Dividends£29.20+£0
Yr 8 Interest£1.24+£0
Yr 8 Profit from sales-£10,795.53+£0
Yr 8 proj avg monthly profit-£1,199.95(-24.6%)+£31.57
Total Dividends£11,798.12+£0
Total Interest£1.24+£0
Total Profit from sales£17,298.53+£0
Average monthly cash profit£309.00(6.3%)-£0.77
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance49%+0%

GAW:Games Workshop went back into profit, which is a rare state of affairs for the ISA. No sign of my other magic formula shares getting into profit so I can't bed & ISA them yet.



Only just above the trend line and running parallel with it again

The SIPP looks like this after week 387 overall and week 23 of year 8.




Weekly Change
Cash£194.97
+£0
Portfolio cost£92,367.69
+£0
Portfolio sell value
(bid price - commission)
£29,531.51(-68.0%)-£130.63
Potential profits£363.42
+£262.44
Yr 8 Dividends£124.95
+£0
Yr 8 Interest£1.78
+£0
Yr 8 Profit from sales-£9,820.16
+£0
Yr 8 proj avg monthly profit-£1,836.94(-35.4%)+£83.49
Total Dividends£14,267.73
+£0
Total Interest£2.03
+£0
Total Profit from sales£10,613.59
+£0
Average monthly cash profit£266.84(5.1%)-£0.69
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance38%+0%

Great news on the NUM:Numis Corp buy-out, and along with a small rise in EDV:Endeavour Mining, potential profits went up £262. That reduced the impact of the OPTI:Optibiotix drop so value only went down by £130.



Same as ISA

The trading account looks like this after week 353 overall and week 41 of year 7.




Weekly Change
Cash£20.25
+£0
Portfolio cost£1,763.50
+£0
Portfolio sell value
(bid price - commission)
£1,050.45(-40.4%)-£12.35
Potential profits£0
+£0
Year 7 Dividends£0.00
+£0
Year 7 Interests£0.02
+£0
Year 7 Profit-£1,157.99
+£0
Yr 7 proj avg monthly profit-£122.32(-83.2%)+£3.05
Dividends£60.10
+£0
Interest£0.02
+£0
Profit from sales-£930.69
+£0
Average monthly cash profit-£10.69(-7.3%)+£0.03
(Sold stocks profit + Dividends
- Fees / Months)

Just the OPTI:Optibiotix drop dragging value down by £12.



Almost touching the trend line and will no doubt soon cross it.

OPTI:Optibiotix is at an all time low since I bought it. We're assured by the CEO that there's loads going on, but none of it seems to be resulting in profit, and there's still no sign of a Sweetbiotix contract. I guess there's no point in moaning. I made my decision to invest way too much in a startup company producing a product that the market isn't ready for yet. It was a much higher risk than I anticipated at the time, and one I don't intend to repeat. For now I'm stuck invested and can do nothing but hope for the best.

No comments:

Post a Comment